Abstract:N 6 -methyladenosine (m 6 A) is a prevalent RNA modification that plays a key role in regulating eukaryotic cellular mRNA functions. RNA m 6 A modification is regulated by two groups of cellular proteins, writers and erasers that add or remove m 6 A, respectively. HIV-1 RNA contains m 6 A modifications that modulate viral infection and gene expression in CD4 + T cells. However, it remains unclear whether m 6 A modifications of HIV-1 RNA modulate innate immune responses in myeloid cells that are important for antiviral immunity. Here we show that m 6 A modification of HIV-1 RNA suppresses the expression of antiviral cytokine type-I interferon (IFN-I) in differentiated human monocytic cells and primary monocyte-derived macrophages. Transfection of differentiated monocytic U937 cells with HIV-1 RNA fragments containing a single m 6 A-modification significantly reduced IFN-I mRNA expression relative to their unmodified RNA counterparts. We generated HIV-1 with altered m 6 A levels of RNA by manipulating the expression of the m 6 A erasers (FTO and ALKBH5) or pharmacological inhibition of m 6 A addition in virus-producing cells, or by treating HIV-1 RNA with recombinant FTO in vitro . HIV-1 RNA transfection or viral infection of differentiated U937 cells and primary macrophages demonstrated that HIV-1 RNA with decreased m 6 A levels enhanced IFN-I expression, whereas HIV-1 RNA with increased m 6 A modifications had opposite effects. Our mechanistic studies indicated that m 6 A of HIV-1 RNA escaped retinoic acid-induced gene I (RIG-I)-mediated RNA sensing and activation of the transcription factors IRF3 and IRF7 that drive IFN-I gene expression. Together, these findings suggest that m 6 A modifications of HIV-1 RNA evade innate immune sensing in myeloid cells.

N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I

N 6-Methyladenosine RNA Modification Suppresses Antiviral Innate Sensing Pathways Via Reshaping Double-Stranded RNA

N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA

N6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling

N6-methyladenosine modification—a key player in viral infection

N6-methyladenosine and viral infection

Regulation of Antiviral Immune Response by N6-Methyladenosine of mRNA

Viral N6-methyladenosine Upregulates Replication and Pathogenesis of Human Respiratory Syncytial Virus.

m6A modification controls the innate immune response to infection by targeting type I interferons

N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection

N 6 -Methyladenosine and Its Implications in Viruses

Regulation of Virus Replication and T Cell Homeostasis by N6-Methyladenosine

Global profiling reveals common and distinct N6-methyladenosine (m6A) regulation of innate immune responses during bacterial and viral infections

Regulation of Virus Replication and T Cell Homeostasis by N 6 -Methyladenosine

m6A Reader Proteins: The Executive Factors in Modulating Viral Replication and Host Immune Response

The Roles of N6-Methyladenosine Modification in Plant-RNA Virus Interactions

Pathogenic Roles of M6a Modification in Viral Infection and Virus-Driven Carcinogenesis.

Analysis of N6-Methyladenosine Modification of HBV RNA by Methylated RNA Immunoprecipitation

Regulatory Effect of M6a Modification on Different Viruses

m6A modification of plant virus enables host recognition by NMD factors in plants

N6-methyladenosine modification of HIV-1 RNA suppresses type-I interferon induction in differentiated monocytic cells and primary macrophages